GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Metabasis Therapeutics, Inc (MBRX) [hlAlert]

Rating:
Sector Outperform
MBRX
down 85.66 %

Metabasis Therapeutics, Inc (MBRX) rated Sector Outperform with price target $5 by CIBC Wrld Mkts

Posted on: Wednesday,  Dec 19, 2007  8:25 AM ET by CIBC Wrld Mkts

CIBC Wrld Mkts rated Sector Outperform Metabasis Therapeutics, Inc (NASDAQ: MBRX) on 12/19/2007, when the stock price was $2.65.
Since then, Metabasis Therapeutics, Inc has lost 85.66% as of 01/27/2010's recent price of $0.38.
If you would have followed this CIBC Wrld Mkts's recommendation on MBRX, you would have lost 85.66% of your investment in 770 days.

Metabasis Therapeutics, Inc. discovers and develops drugs for the treatment of liver diseases and metabolic diseases linked to pathways in the liver. They have established a broad pipeline of internally discovered product candidates using their proprietary technologies, NuMimetic and HepDirect.

CIBC World Markets strives to deliver leading edge investment research to investing clients through our multi-faceted, firm-wide research product offering. Our research has consistently been recognized as a top research source for its breadth of coverage, industry knowledge and quality of work in generating profitable and timely investment ideas. We provide in-depth coverage for all of the major sectors of the Canadian economy and select coverage of U.S. companies. Our analytical teams remain committed to identifying trends early and developing exploitable investment opportunities across the market capitalization spectrum. With the continued growth in quantitative and computerized investing strategies, we have also developed leading edge quantitative and technical research products to partner with our fundamental approach. Our products are available through several automated avenues: email, website, and third-party market vendors. Client service is our driving force and we constantly advance in offering greater product customization options.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/19/2007 8:25 AM Buy
None
2.65 5.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD down  -81.21 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy